兴齐眼药(300573.SZ)发布上半年业绩，归母净利润3.35亿元，增长97.75%

Core Viewpoint - The company reported significant growth in both revenue and net profit for the first half of 2025, indicating strong operational performance and financial health [1] Financial Performance - The company's operating revenue reached 1.163 billion yuan, representing a year-on-year increase of 30.38% [1] - The net profit attributable to shareholders was 335 million yuan, showing a remarkable year-on-year growth of 97.75% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 331 million yuan, reflecting a year-on-year increase of 96.30% [1] - The basic earnings per share stood at 1.36 yuan [1]